SynthesisFrontiers in oncology2025

PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-analysis.

Chao Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.